News

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results.

11/14/2024

Exicure, Inc. Receives Extension from Nasdaq Hearings Panel

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today that on September 17, 2024, the Company received notice that the Nasdaq Hearings Panel (“Panel”) granted an extension to continue the Company's listing subject to the Company evidencing compliance with all applicable criteria for continued listing on The Nasdaq Capital Market by November 14, 2024. The Company is diligently working to timely satisfy the terms of the Panel's requests and to ensure.

09/18/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Exicure, Inc. (XCUR) a buy, sell, or hold?

Exicure, Inc. (XCUR) can sell. Click on Rating Page for detail.

What is Exicure, Inc.'s stock price?

The price of Exicure, Inc. (XCUR) is 11.2999 and it was updated on 2024-11-20 13:00:30.

Is Exicure, Inc. (XCUR) overvalued or undervalued?

Currently Exicure, Inc. (XCUR) is in undervalued.

News

From:

To:

News
Exicure, Inc. Announces 1-for-5 Reverse Stock Split CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, “the Company”) today announced that it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock (the “Reverse Stock Split”). The Company expects that the Reverse Stock Split will become effective at 5:00 pm on Tuesday, August 27, 2024, and its common stock will begin trading on a split-adjusted basis at the open of trading on Wednesday, August 28, 2024 under the new CUSIP number 30205M 309. Exicure's common stock. Mon, Aug. 26, 2024
Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics. Thu, Aug. 08, 2024
Exicure, Inc. Receives Positive Listing Determination from Nasdaq CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Receives Positive Listing Determination from Nasdaq. Thu, Aug. 01, 2024
Why Is Exicure (XCUR) Stock Down 27% Today? Exicure (NASDAQ: XCUR ) stock is dropping on Monday after the prior early-stage pharmaceutical company's shares underwent a rally on Friday. That rally resulted in shares of XCUR stock rising 76% higher during normal trading hours. Mon, Jul. 22, 2024
Exicure, Inc. Reports First Quarter 2024 Financial Results CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, the “Company”), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value. First Quarter 2024 Finan. Mon, Jun. 17, 2024

SEC Filings

SEC Filings
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/14/2024
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/14/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/30/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/18/2024
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 09/16/2024
Exicure, Inc. (XCUR) - 4 SEC Filings 09/16/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/13/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/26/2024
Exicure, Inc. (XCUR) - 4 SEC Filings 08/21/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/19/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/15/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/13/2024
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/13/2024
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 08/05/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/01/2024
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 07/30/2024
Exicure, Inc. (XCUR) - PRE 14A SEC Filings 07/19/2024
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 07/02/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 07/01/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/25/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/17/2024
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 06/17/2024
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 06/11/2024
Exicure, Inc. (XCUR) - ARS SEC Filings 06/11/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/06/2024
Exicure, Inc. (XCUR) - 10-Q/A - Quarterly Report SEC Filings 06/06/2024
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 06/06/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/23/2024
Exicure, Inc. (XCUR) - 4 SEC Filings 05/23/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/16/2024
Exicure, Inc. (XCUR) - 10-Q/A - Quarterly Report SEC Filings 05/16/2024
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/16/2024
Exicure, Inc. (XCUR) - NT 10-Q - Quarterly Report SEC Filings 05/15/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/22/2024
Exicure, Inc. (XCUR) - NT 10-K - Current report SEC Filings 04/01/2024
Exicure, Inc. (XCUR) - 4 SEC Filings 03/06/2024
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 03/04/2024
Exicure, Inc. (XCUR) - 4 SEC Filings 03/04/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/05/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/16/2024
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/01/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 12/01/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/28/2023
Exicure, Inc. (XCUR) - NT 10-Q - Quarterly Report SEC Filings 11/14/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/06/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 09/29/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/27/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/13/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 08/31/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/23/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 08/18/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/11/2023
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/11/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/09/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 08/08/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/04/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 07/14/2023
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 07/14/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 06/28/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 06/27/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 06/27/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/14/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/06/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/01/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/26/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 05/25/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/19/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/18/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 05/17/2023
Exicure, Inc. (XCUR) - NT 10-Q - Quarterly Report SEC Filings 05/15/2023
Exicure, Inc. (XCUR) - 3/A SEC Filings 05/15/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 05/15/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/11/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/09/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 05/09/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 05/05/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/04/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/02/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 05/01/2023
Exicure, Inc. (XCUR) - 10-K/A - Current report SEC Filings 05/01/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/27/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 04/13/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/27/2023
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/27/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 03/09/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 03/09/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 03/06/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 03/03/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/02/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/24/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/21/2023
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 02/14/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 02/13/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/10/2023
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 02/09/2023
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 01/23/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/20/2023
Exicure, Inc. (XCUR) - 4 SEC Filings 01/04/2023
Exicure, Inc. (XCUR) - 3 SEC Filings 01/04/2023
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/30/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 12/19/2022
Exicure, Inc. (XCUR) - 4 SEC Filings 12/19/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/16/2022
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 12/14/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/14/2022
Exicure, Inc. (XCUR) - SC 13G SEC Filings 12/06/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 12/05/2022
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 11/14/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/14/2022
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 11/10/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 10/31/2022
Exicure, Inc. (XCUR) - PRE 14A SEC Filings 10/31/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/31/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/27/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/24/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/15/2022
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/15/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 08/11/2022
Exicure, Inc. (XCUR) - EFFECT SEC Filings 07/21/2022
Exicure, Inc. (XCUR) - EFFECT SEC Filings 07/21/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 07/20/2022
Exicure, Inc. (XCUR) - 424B3 SEC Filings 07/20/2022
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 07/18/2022
Exicure, Inc. (XCUR) - CORRESP SEC Filings 07/18/2022
Exicure, Inc. (XCUR) - S-3 SEC Filings 07/11/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/29/2022
Exicure, Inc. (XCUR) - 4 SEC Filings 06/15/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/13/2022
Exicure, Inc. (XCUR) - SC 13D SEC Filings 06/01/2022
Exicure, Inc. (XCUR) - SC 13D SEC Filings 05/31/2022
Exicure, Inc. (XCUR) - 3 SEC Filings 05/31/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/27/2022
Exicure, Inc. (XCUR) - 4 SEC Filings 05/20/2022
Exicure, Inc. (XCUR) - 3 SEC Filings 05/20/2022
Exicure, Inc. (XCUR) - 4 SEC Filings 05/19/2022
Exicure, Inc. (XCUR) - 4 SEC Filings 05/18/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/16/2022
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/16/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/13/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 05/11/2022
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 04/12/2022
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 04/12/2022
Exicure, Inc. (XCUR) - PRE 14A SEC Filings 04/01/2022
Exicure, Inc. (XCUR) - S-8 SEC Filings 03/25/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/25/2022
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/25/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/18/2022
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 02/25/2022
Exicure, Inc. (XCUR) - SC 13G SEC Filings 02/15/2022
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 02/14/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/04/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/18/2022
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/05/2022
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 12/22/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 12/22/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/16/2021
Exicure, Inc. (XCUR) - 424B5 SEC Filings 12/16/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/10/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 11/23/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/19/2021
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/19/2021
Exicure, Inc. (XCUR) - NT 10-Q - Quarterly Report SEC Filings 11/15/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/06/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 09/08/2021
Exicure, Inc. (XCUR) - SC 13G SEC Filings 08/20/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/12/2021
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/12/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/05/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/02/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 07/15/2021
Exicure, Inc. (XCUR) - 3 SEC Filings 06/15/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 06/04/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/03/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/02/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 05/20/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 05/14/2021
Exicure, Inc. (XCUR) - 3 SEC Filings 05/14/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/13/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/12/2021
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/12/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 05/04/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 04/29/2021
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 04/22/2021
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 04/22/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/20/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/09/2021
Exicure, Inc. (XCUR) - S-8 SEC Filings 03/12/2021
Exicure, Inc. (XCUR) - S-8 SEC Filings 03/11/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/11/2021
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/11/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/09/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 03/08/2021
Exicure, Inc. (XCUR) - 3 SEC Filings 03/08/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/03/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/11/2021
Exicure, Inc. (XCUR) - EFFECT SEC Filings 01/08/2021
Exicure, Inc. (XCUR) - EFFECT SEC Filings 01/07/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/07/2021
Exicure, Inc. (XCUR) - CORRESP SEC Filings 01/05/2021
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/05/2021
Exicure, Inc. (XCUR) - 4 SEC Filings 01/05/2021
Exicure, Inc. (XCUR) - 3 SEC Filings 01/05/2021
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 12/23/2020
Exicure, Inc. (XCUR) - S-3 SEC Filings 12/21/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/12/2020
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/12/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/01/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/18/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/16/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/12/2020
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/12/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 07/08/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/16/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 06/16/2020
Exicure, Inc. (XCUR) - EFFECT SEC Filings 06/10/2020
Exicure, Inc. (XCUR) - EFFECT SEC Filings 06/10/2020
Exicure, Inc. (XCUR) - EFFECT SEC Filings 06/09/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/09/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 06/09/2020
Exicure, Inc. (XCUR) - POS AM SEC Filings 06/08/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/08/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 06/08/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 06/05/2020
Exicure, Inc. (XCUR) - 3 SEC Filings 06/05/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 05/21/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/14/2020
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/14/2020
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 04/21/2020
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 04/21/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/30/2020
Exicure, Inc. (XCUR) - 4 SEC Filings 03/16/2020
Exicure, Inc. (XCUR) - S-8 SEC Filings 03/10/2020
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/10/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/05/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/03/2020
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 02/14/2020
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 02/10/2020
Exicure, Inc. (XCUR) - SC 13G SEC Filings 02/10/2020
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/23/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 12/23/2019
Exicure, Inc. (XCUR) - 424B5 SEC Filings 12/20/2019
Exicure, Inc. (XCUR) - 424B5 SEC Filings 12/18/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 12/11/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/14/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/07/2019
Exicure, Inc. (XCUR) - 424B3 SEC Filings 11/07/2019
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/07/2019
Exicure, Inc. (XCUR) - SC 13G SEC Filings 10/07/2019
Exicure, Inc. (XCUR) - 424B3 SEC Filings 09/24/2019
Exicure, Inc. (XCUR) - 10-K/A - Current report SEC Filings 09/23/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 09/12/2019
Exicure, Inc. (XCUR) - SC 13D SEC Filings 08/12/2019
Exicure, Inc. (XCUR) - SC 13D SEC Filings 08/09/2019
Exicure, Inc. (XCUR) - 424B3 SEC Filings 08/09/2019
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 08/08/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/08/2019
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/08/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/07/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 08/06/2019
Exicure, Inc. (XCUR) - 3 SEC Filings 08/06/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 08/05/2019
Exicure, Inc. (XCUR) - 3 SEC Filings 08/05/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/02/2019
Exicure, Inc. (XCUR) - 424B5 SEC Filings 08/01/2019
Exicure, Inc. (XCUR) - CERT SEC Filings 07/30/2019
Exicure, Inc. (XCUR) - 8-A12B SEC Filings 07/30/2019
Exicure, Inc. (XCUR) - 424B5 SEC Filings 07/30/2019
Exicure, Inc. (XCUR) - EFFECT SEC Filings 07/25/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 07/23/2019
Exicure, Inc. (XCUR) - CORRESP SEC Filings 07/22/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 07/22/2019
Exicure, Inc. (XCUR) - 3 SEC Filings 07/22/2019
Exicure, Inc. (XCUR) - S-3/A SEC Filings 07/11/2019
Exicure, Inc. (XCUR) - CORRESP SEC Filings 07/11/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/27/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/17/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 06/14/2019
Exicure, Inc. (XCUR) - 10-Q/A - Quarterly Report SEC Filings 05/14/2019
Exicure, Inc. (XCUR) - 424B3 SEC Filings 05/10/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/08/2019
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/08/2019
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 04/30/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/22/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/21/2019
Exicure, Inc. (XCUR) - 424B3 SEC Filings 03/19/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/19/2019
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 03/18/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/18/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/14/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/14/2019
Exicure, Inc. (XCUR) - S-3 SEC Filings 03/08/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/08/2019
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/08/2019
Exicure, Inc. (XCUR) - 4 SEC Filings 03/01/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/22/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 02/01/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 01/07/2019
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/06/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 11/06/2018
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/06/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 10/11/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/10/2018
Exicure, Inc. (XCUR) - EFFECT SEC Filings 10/09/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 10/09/2018
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 10/04/2018
Exicure, Inc. (XCUR) - CORRESP SEC Filings 10/03/2018
Exicure, Inc. (XCUR) - S-1 SEC Filings 09/21/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 09/10/2018
Exicure, Inc. (XCUR) - D SEC Filings 08/31/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/28/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 08/08/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 08/06/2018
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 08/06/2018
Exicure, Inc. (XCUR) - 4 SEC Filings 08/03/2018
Exicure, Inc. (XCUR) - 4 SEC Filings 06/21/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/20/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/30/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 05/15/2018
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 05/15/2018
Exicure, Inc. (XCUR) - DEFA14A SEC Filings 04/30/2018
Exicure, Inc. (XCUR) - DEF 14A SEC Filings 04/30/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/30/2018
Exicure, Inc. (XCUR) - 4 SEC Filings 04/30/2018
Exicure, Inc. (XCUR) - 3 SEC Filings 04/24/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 04/20/2018
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 03/09/2018
Exicure, Inc. (XCUR) - 10-K - Current report SEC Filings 03/09/2018
Exicure, Inc. (XCUR) - S-8 SEC Filings 02/13/2018
Exicure, Inc. (XCUR) - EFFECT SEC Filings 02/07/2018
Exicure, Inc. (XCUR) - 424B3 SEC Filings 02/07/2018
Exicure, Inc. (XCUR) - S-1/A SEC Filings 02/06/2018
Exicure, Inc. (XCUR) - CORRESP SEC Filings 02/05/2018
Exicure, Inc. (XCUR) - S-1/A SEC Filings 01/26/2018
Exicure, Inc. (XCUR) - CORRESP SEC Filings 01/26/2018
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 01/24/2018
Exicure, Inc. (XCUR) - S-1/A SEC Filings 01/12/2018
Exicure, Inc. (XCUR) - CORRESP SEC Filings 01/12/2018
Exicure, Inc. (XCUR) - CT ORDER SEC Filings 01/11/2018
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 12/18/2017
Exicure, Inc. (XCUR) - S-1 SEC Filings 11/28/2017
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 11/17/2017
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/14/2017
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 11/14/2017
Exicure, Inc. (XCUR) - CORRESP SEC Filings 11/07/2017
Exicure, Inc. (XCUR) - 8-K/A - Current report SEC Filings 11/07/2017
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/06/2017
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 11/02/2017
Exicure, Inc. (XCUR) - DEF 14C SEC Filings 10/26/2017
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 10/25/2017
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 10/20/2017
Exicure, Inc. (XCUR) - SC 13G/A SEC Filings 10/18/2017
Exicure, Inc. (XCUR) - SC 13D/A SEC Filings 10/18/2017
Exicure, Inc. (XCUR) - PRE 14C SEC Filings 10/16/2017
Exicure, Inc. (XCUR) - D SEC Filings 10/10/2017
Exicure, Inc. (XCUR) - SC 13D SEC Filings 10/06/2017
Exicure, Inc. (XCUR) - 3 SEC Filings 10/06/2017
Exicure, Inc. (XCUR) - SC 13G SEC Filings 10/05/2017
Exicure, Inc. (XCUR) - 3 SEC Filings 10/05/2017
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 10/02/2017
Exicure, Inc. (XCUR) - 4 SEC Filings 09/28/2017
Exicure, Inc. (XCUR) - 3 SEC Filings 09/28/2017
Exicure, Inc. (XCUR) - 4 SEC Filings 09/26/2017
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 09/12/2017
Exicure, Inc. (XCUR) - SC 14F1 SEC Filings 08/08/2017
Exicure, Inc. (XCUR) - 10-Q - Quarterly Report SEC Filings 07/11/2017
Exicure, Inc. (XCUR) - D SEC Filings 07/03/2017
Exicure, Inc. (XCUR) - SC 13G SEC Filings 06/26/2017
Exicure, Inc. (XCUR) - SC 13D SEC Filings 06/26/2017
Exicure, Inc. (XCUR) - 8-K - Current report SEC Filings 06/19/2017
Exicure, Inc. (XCUR) - 4 SEC Filings 06/19/2017
Exicure, Inc. (XCUR) - 3 SEC Filings 05/22/2017
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 05/03/2017
Exicure, Inc. (XCUR) - CORRESP SEC Filings 04/20/2017
Exicure, Inc. (XCUR) - 10-12G/A SEC Filings 04/20/2017
Exicure, Inc. (XCUR) - UPLOAD SEC Filings 04/17/2017
Exicure, Inc. (XCUR) - 10-12G SEC Filings 03/21/2017

Press Releases

StockPrice Release
Exicure, inc. enters into purchase agreements for $1.3 million and $8.7 million equity financing and reports third quarter 2024 financial results 11/14/2024
Exicure, inc. receives extension from nasdaq hearings panel 09/18/2024
Exicure, inc. announces 1-for-5 reverse stock split 08/26/2024
Exicure, inc. recruits head of corporate development and bioinformatics 08/08/2024
Exicure, inc. receives positive listing determination from nasdaq 08/01/2024
Exicure, inc. reports first quarter 2024 financial results 06/17/2024
Exicure, inc. reports full year 2023 financial results 06/06/2024
Exicure, inc. received nasdaq notice of a delisting determination 05/23/2024
Exicure, inc. reports third quarter 2023 financial results 05/16/2024
Exicure, inc. received nasdaq delinquency notice on late filing of its form 10-k 04/22/2024
Exicure, inc. and bluejay therapeutics inc. enter into a patent license agreement to develop cavrotolimod for the treatment of hepatitis 02/05/2024
Exicure, inc. received nasdaq delinquency notice on late filing of its form 10-q 11/28/2023
Exicure, inc. announces appointment of new ceo and cfo and changes to board of directors 08/23/2023
Exicure, inc. reports second quarter 2023 financial results and provides corporate update 08/11/2023
Exicure, inc. reports first quarter 2023 financial results and provides corporate update 07/14/2023
Exicure, inc. announces support of ceo in its ongoing exploration of strategic alternatives 05/26/2023
Exicure, inc. received nasdaq delinquency notice on late filing of its form 10-q 05/19/2023
Exicure, inc. reports full year 2022 financial results and provides corporate update 03/27/2023
Exicure, inc. announces closing of private placement transaction with cbi usa, inc. and changes to the board of directors 02/24/2023
Exicure, inc. announces termination of abbvie and ipsen collaboration agreements 12/14/2022
Exicure, inc. enters into definitive agreement with cbi usa, inc. for $5.4 million equity financing and announces implementation of strategic measure to reduce cash burn and prioritize strategic alternatives 09/26/2022
Exicure announces presentation at chardan's 6th annual genetic medicines conference 09/01/2022
Exicure, inc. announces receipt of nasdaq notice of non-compliance and implementation of one-for-thirty reverse stock split 06/29/2022
Exicure, inc. announces adjournment of annual meeting of stockholders 05/27/2022
Exicure announces presentation at 2022 h.c. wainwright global life sciences conference 05/17/2022
Exicure announces $5 million raise in private placement transaction priced at market premium 05/10/2022
Exicure to present at upcoming tides usa oligonucleotide & peptide therapeutics conference 05/09/2022
Exicure, inc. reports full year 2021 financial results and corporate progress 03/25/2022
Did you acquire (xcur) before january 7, 2021? should management be held accountable for investors losses? 02/17/2022
Exicure shareholder alert 02/11/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 02/10/2022
The law offices of frank r. cruz reminds investors of looming deadline in the class action lawsuit against exicure, inc. (xcur) 02/10/2022
Deadline tomorrow reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 02/10/2022
Xcur final deadline: rosen, respected investor counsel, encourages exicure, inc. investors to secure counsel before important friday deadline in securities class action - xcur 02/10/2022
Deadline friday notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 02/09/2022
Deadline friday alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 02/08/2022
The law offices of frank r. cruz announces the filing of a securities class action on behalf of exicure, inc. (xcur) investors 02/07/2022
Friday deadline reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 02/07/2022
Exicure class action reminder 02/06/2022
Glancy prongay & murray llp expands class period in the securities fraud lawsuit against exicure, inc. (xcur) 02/04/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 02/04/2022
Exicure, inc. announces leadership transition and changes to the board of directors 02/04/2022
Rosen, a respected and leading firm, encourages exicure, inc. investors with losses over $100k to secure counsel before important february 11 deadline in securities class action - xcur 02/03/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 02/02/2022
Exicure shareholder alert 02/01/2022
Xcur loss alert: rosen, leading investor counsel, encourages exicure, inc. investors with losses to secure counsel before important february 11 deadline in securities class action - xcur 02/01/2022
Shareholder action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 02/01/2022
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/31/2022
Exicure shareholder alert 01/28/2022
Investor action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/28/2022
Xcur investors have opportunity to lead exicure, inc. securities fraud lawsuit 01/28/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 01/27/2022
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/26/2022
Rosen, global investor counsel, encourages exicure, inc. investors with losses over $100k to secure counsel before important february 11 deadline in securities class action - xcur 01/25/2022
Investor action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/25/2022
Shareholder action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/24/2022
Rosen, a top ranked law firm, encourages exicure, inc. investors with losses over $100k to secure counsel before important february 11 deadline in securities class action - xcur 01/23/2022
Exicure shareholder alert 01/21/2022
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/21/2022
Investor action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/20/2022
Xcur investors have opportunity to lead exicure, inc. securities fraud lawsuit 01/20/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 01/19/2022
Shareholder action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/19/2022
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/18/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 01/17/2022
Exicure shareholder alert 01/17/2022
Rosen, a globally recognized firm, encourages exicure, inc. investors with losses to secure counsel before important deadline in securities class action - xcur 01/17/2022
Investor action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/17/2022
Exicure update 01/16/2022
Exicure class action reminder 01/14/2022
Shareholder action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/14/2022
Rosen, a leading law firm, encourages exicure, inc. investors to secure counsel before important february 11 deadline in securities class action - xcur 01/14/2022
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/13/2022
Exicure shareholder alert 01/12/2022
Investor action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/12/2022
Shareholder action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/11/2022
The law offices of frank r. cruz announces the filing of a securities class action on behalf of exicure, inc. (xcur) investors 01/10/2022
Rosen, trusted investor counsel, encourages exicure, inc. investors to secure counsel before important deadline in securities class action - xcur 01/09/2022
Exicure class action reminder 01/09/2022
Rosen, respected investor counsel, encourages exicure, inc. investors with losses to secure counsel before important february 11 deadline in securities class action - xcur 01/07/2022
Investor action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/07/2022
Shareholder alert: pomerantz law firm investigates claims 01/06/2022
Investor action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/06/2022
Exicure shareholder alert 01/05/2022
Shareholder action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/05/2022
Xcur investors have opportunity to lead exicure, inc. securities fraud lawsuit 01/05/2022
Investor action notice: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/04/2022
Xcur investor alert: bronstein, gewirtz & grossman, llc notifies exicure, inc. investors of class action and encourages shareholders to contact the firm 01/04/2022
Investor action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 01/03/2022
Exicure update 01/02/2022
Rosen, leading trial attorneys, encourages exicure, inc. investors with losses to secure counsel before important deadline in securities class action - xcur 01/01/2022
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 12/31/2021
Rosen, skilled investor counsel, encourages exicure, inc. investors to secure counsel before important february 11 deadline in securities class action - xcur 12/30/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 12/29/2021
Rosen, a globally recognized law firm, encourages exicure, inc. investors with losses to secure counsel before important february 11 deadline in securities class action - xcur 12/23/2021
Xcur investor alert: bronstein, gewirtz & grossman, llc notifies exicure, inc. investors of class action and encourages shareholders to contact the firm 12/21/2021
Xcur shareholder alert: robbins llp reminds investors of class action against exicure, inc. (xcur) 12/21/2021
Deadline reminder: law offices of howard g. smith reminds investors of looming deadline in the class action lawsuit against exicure, inc. (xcur) 12/20/2021
Rosen, a leading law firm, encourages exicure, inc. investors to secure counsel before important february 11 deadline in securities class action - xcur 12/18/2021
Rosen, global investor counsel, encourages exicure, inc. investors to secure counsel before important february 11 deadline in securities class action – xcur 12/17/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of exicure, inc. - xcur 12/16/2021
Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against exicure, inc. (xcur) 12/16/2021
Xcur shareholders: robbins llp informs investors of class action against exicure, inc. (xcur) 12/15/2021
The law offices of frank r. cruz announces the filing of a securities class action on behalf of exicure, inc. (xcur) investors 12/15/2021
Exicure shareholder alert 12/14/2021
Exicure, inc. announces $11.5 million registered direct offering priced at-the-market under nasdaq rules 12/14/2021
Equity alert: rosen, a top ranked law firm, encourages exicure, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – xcur 12/14/2021
Shareholder action reminder: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 12/14/2021
Exicure alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against exicure, inc. and encourages investors to contact the firm 12/13/2021
Shareholder action alert: the schall law firm encourages investors in exicure, inc. with losses of $100,000 to contact the firm 12/13/2021
Investor alert: law offices of howard g. smith announces the filing of a securities class action on behalf of exicure, inc. (xcur) investors 12/13/2021
Xcur class action notice: glancy prongay & murray llp files securities fraud lawsuit against exicure, inc. 12/13/2021
Exicure update 12/12/2021
Exicure, inc. announces results of internal investigation and implementation of strategic measures to reduce cash burn and prioritize pipeline focus 12/10/2021
Exicure shareholder alert 12/08/2021
Exicure investor alert 12/07/2021
Rosen, trusted investor counsel, encourages exicure, inc. investors with losses to inquire about class action investigation - xcur 12/07/2021
Exicure update 12/05/2021
Investigation notice: the schall law firm announces it is investigating claims against exicure, inc. and encourages investors with losses of $100,000 to contact the firm 12/03/2021
Exicure shareholder alert 12/01/2021
Exicure investor alert 11/30/2021
Investigation alert: the schall law firm announces it is investigating claims against exicure, inc. and encourages investors with losses of $100,000 to contact the firm 11/28/2021
Exicure investor alert 11/28/2021
Exicure update 11/26/2021
Exicure to present at the chardan virtual 5th annual genetic medicines conference 10/04/2021
Exicure to participate in upcoming scientific conferences 09/15/2021
Exicure to participate in upcoming investor conferences 09/01/2021
Ipsen and exicure enter into exclusive collaboration targeting rare neurodegenerative disorders 08/02/2021
Exicure announces appointment of brian c. bock as chief financial officer (cfo) 05/13/2021
Spherical nucleic acid technology shows promising results in phase 0 trial in patients with glioblastoma at northwestern university 03/11/2021
Exicure, inc. reports full year 2020 financial results and corporate progress 03/11/2021
Exicure announces appointments of elizabeth garofalo, m.d., and andrew sassine to its board of directors 03/09/2021
Exicure announces presentation at 2021 h.c. wainwright global life sciences conference 02/23/2021
Exicure announces webcast of presentation at 2021 hc wainwright bioconnect conference 12/29/2020
Exicure and allergan enter into collaboration, option and license agreement to discover and develop sna-based treatments for hair loss disorders 11/14/2019

More Headlines

News
Exicure, Inc. Reports Full Year 2023 Financial Results CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Reports Full Year 2023 Financial Results. 06/06/2024
Exicure, Inc. Received Nasdaq Notice of a Delisting Determination CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received notice of a delisting determination (the “Staff Delisting Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Staff Delisting Determination notified the Company that since it has not yet filed its Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) per Nasdaq Listing Rule 5250(c)(1) (the “Rule”) by Nasdaq's extended d. 05/23/2024
Exicure, Inc. Reports Third Quarter 2023 Financial Results CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value. Third Quarter 2023 Financial Results Ca. 05/16/2024
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on April 17, 2024 notifying the Company that, as a result of the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all. 04/22/2024
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis CHICAGO--(BUSINESS WIRE)--Exicure, Inc., (NASDAQ:XCUR) a company that historically developed nucleic acid therapies, and Bluejay Therapeutics, Inc., a private clinical stage biopharmaceutical company focused on viral and liver diseases, announced today that Bluejay Therapeutics, Inc. ("Bluejay") and Exicure, Inc. ("Exicure") entered into a patent license agreement to develop cavrotolimod for potential treatment for hepatitis. Under the terms of the agreement, Bluejay will receive an exclusive l. 02/05/2024
Why Is Exicure (XCUR) Stock Up 57% Today? Exicure (NASDAQ: XCUR ) stock is rising higher on Friday despite a lack of news from the early-stage biotechnology company. Exicure hasn't released any recent press releases or made any filings that would result in today's stock rally. 12/08/2023
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on November 22, 2023 notifying the Company that, as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies. 11/28/2023
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors CHICAGO--(BUSINESS WIRE)--Exicure, Inc. announces appointment of new CEO and CFO and changes to Board of Directors. 08/23/2023
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update CHICAGO--(BUSINESS WIRE)--Exicure, Inc. reports second quarter 2023 financial results and provides corporate update. 08/11/2023
3 Nano-Cap Penny Stocks to Buy for Explosive Gains in 2023 Nano-cap penny stocks are arguably the most volatile and speculative investments you can make other than nano-cap cryptos. Shares of these small businesses generally have a market capitalization lower than $50 million. 04/14/2023
Penny Stocks To Buy: 6 Insider Picks Before 2023 Insiders are buying these penny stocks but are they worth the risk? The post Penny Stocks To Buy: 6 Insider Picks Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 12/21/2022
3 Top Penny Stocks To Buy According To Insiders Before 2023 Insiders are buying these penny stocks but are they worth the risk? The post 3 Top Penny Stocks To Buy According To Insiders Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 12/20/2022
Exicure (XCUR) Stock: 1-For-30 Reverse Split Goes Into Effect A reverse stock split of Exicure, Inc. (NASDAQ: XCUR) of 1-for-30 has gone into effect. These are the details. 06/30/2022
What to Know About Buying Penny Stocks on May 20th Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 20th appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 05/20/2022
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference CHICAGO--(BUSINESS WIRE)--Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022. 05/09/2022
Check These 3 Hot Penny Stocks Out For Your List This Week Here are three penny stocks to add to your watchlist this week The post Check These 3 Hot Penny Stocks Out For Your List This Week appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 04/12/2022
Exicure Shares Plunge After Q4 Results Included A Going Concern Risk Exicure Inc (NASDAQ: XCUR) has reported year-end cash, cash equivalents, and short-term investments of $48.3 million that will fund its current operations into Q4 of 2022. The Company said that it expects to continue to generate operating losses and negative operating cash. 03/28/2022
Good Trending Penny Stocks to Buy Now? Check These 3 Out Check these trending penny stocks out for your watchlist The post Good Trending Penny Stocks to Buy Now? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/14/2022
4 Top Penny Stocks To Buy For Under $1 This Week Penny stocks to watch under $1 this week. The post 4 Top Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/09/2022
Popular Reddit Penny Stocks to Watch In February 2022 Check these Reddit penny stocks out for your watchlist right now The post Popular Reddit Penny Stocks to Watch In February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/02/2022
5 Top Penny Stocks To Buy Under $1 On Webull According To Reddit Penny stocks under $1 The post 5 Top Penny Stocks To Buy Under $1 On Webull According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 01/31/2022
Exicure Stock (XCUR) Price Surges Today: Details You Should Know The stock price of Exicure Inc (NASDAQ: XCUR) increased by over 30% pre-market today. These are some details you should know. 01/26/2022
Exicure Stock (XCUR): Why The Price Surged Today The stock price of Exicure Inc (NASDAQ: XCUR) increased by over 60% pre-market today. This is why it happened. 12/14/2021
Exicure Stock Plunges After Results Of Internal Probe, Management Shakeup, Layoffs Exicure Inc's (NASDAQ: XCUR) Audit Committee concluded that Grant Corbett misreported raw data from certain R&D experiments related to XCUR-FXN preclinical program. Dr. Corbett misreported the results of at least three different experiments related solely to efficacy rather than safety. 12/13/2021
Exicure, Inc. (XCUR) Reports Q3 Loss, Lags Revenue Estimates Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -68.75% and 559.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? 11/19/2021
Exicure (XCUR) Stock: Why The Price Substantially Dropped The stock price of Exicure Inc (NASDAQ: XCUR) fell by over 25% pre-market today. This is why it happened. 11/16/2021
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced a presentation at the Chardan Virtual 5th Annual Genetic Medicines Conference on Tuesday, October 5, 2021. 10/04/2021
Exicure to Participate in Upcoming Scientific Conferences CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced participation in TIDES USA 2021 and the 17th Annual Meeting of the Oligonucleotide Therapeutics Society. 09/15/2021
Exicure to Participate in Upcoming Investor Conferences CHICAGO, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure to Participate in Upcoming Investor Conferences. 09/01/2021
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients Exicure Inc (NASDAQ: XCUR) has reported interim results from Phase 1b/2 trial evaluating cavrotolimod (AST-008) in patients with advanced or metastatic solid tumors refractory to anti-PD-(L)1 therapy. The trial is assessing cavrotolimod in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) or Sanofi SA (NASDAQ: SNY) - Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo (cemiplimab) in two primary dose-expansion cohorts, one in Merkel cell carcinoma (MCC) and one in cutaneous squamous cell carcinoma (CSCC), and three exploratory cohorts. 08/05/2021
Ever-Glory stock rockets to pace premarket gainers, Exicure leads most-actives list Shares of Ever-Glory International Group Inc. rocketed 99.1% in active trading early Monday, enough to pace all of the gainers in the premarket session, after the China-based apparel retailer and supply chain solution provider announced a share repurchase program of up to $5 million. Trading volume of 10.9 million shares, which compares with the full-day average of about 755,000 shares, made the stock the second-most active in the premarket. 08/02/2021
XCUR Stock Increases Over 55% Pre-Market: Why It Happened The stock price of Exicure Inc (NASDAQ: XCUR) increased by over 55% pre-market. This is why it happened. 08/02/2021
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders PARIS & CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) and Exicure Inc. (NASDAQ: XCUR) have signed an exclusive collaboration agreement to research, develop, and commercialize novel Spherical Nucleic Acids (SNAs) as potential investigational treatments for Huntington's disease and Angelman syndrome. Oligonucleotides are synthetic structures of nucleic acids that can be used 08/02/2021
Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer (CFO) CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer 05/13/2021
Exicure, Inc. (XCUR) Reports Q4 Loss, Misses Revenue Estimates Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -50.00% and -95.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock? 03/11/2021
Spherical Nucleic Acid Technology Shows Promising Results in Phase 0 Trial in Patients With Glioblastoma at Northwestern University CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spherical Nucleic Acid technology shows promising results in phase 0 trial in patients with glioblastoma at Northwestern University. 03/11/2021
Exicure, Inc. Reports Full Year 2020 Financial Results and Corporate Progress CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure reported fourth quarter and full year financial results for the year ended December 31, 2020 and provided an update on corporate progress. 03/11/2021
Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced the appointment of Elizabeth (Betsy) Garofalo, M.D. and Mr. Andrew Sassine to its Board of Directors. 03/09/2021
Exicure, Inc. (XCUR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Exicure, Inc. (XCUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 03/02/2021
Exicure Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure announced that CEO David Giljohann will present at the 2021 H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021. 02/23/2021
Exicure Announces Webcast of Presentation at 2021 HC Wainwright BIOCONNECT Conference CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure announced that David Giljohann, CEO, will present at the HC Wainwright Virtual BIOCONNECT Conference, January 11-14, 2021. 12/29/2020

Unlock

XCUR Ratings Summary

XCUR Quant Ranking